Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00152750Phase 4Unknown
Phase 4, randomised, double-blind trial in sleep disorder comparing Clonidine with Placebo (2 arms). Primary endpoint: Differences between baseline and final polysomnographic sleep architecture measurements at 8 weeks. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00152750.